bf/NASDAQ:LIFE_icon.png

COM:ATYRPHARMA

aTyr Pharma

  • Stock

USD

Last Close

1.85

04/06 20:00

Market Cap

131.12M

Beta: -

Volume Today

267.89K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-20.01M
-
-24.35M
21.66%
-47.97M
97.01%
-57.85M
20.60%
-48.21M
16.68%
-34.52M
28.40%
-23.76M
31.15%
-16.23M
31.70%
-33.78M
108.11%
-45.34M
34.24%
-50.39M
11.13%
depreciation and amortization
714K
-
829K
16.11%
869K
4.83%
900K
3.57%
713K
20.78%
746K
4.63%
1.37M
83.11%
1.27M
7.32%
1.30M
3.00%
1.70M
29.98%
2.74M
61.71%
deferred income tax
211K
-
469K
122.27%
1.09M
131.56%
733K
32.50%
14K
98.09%
-243K
1,835.71%
-312K
28.40%
113K
136.22%
6K
94.69%
-3.26M
-
stock based compensation
155K
-
1.79M
1,055.48%
4.86M
171.13%
5.03M
3.56%
6.78M
34.90%
3.43M
49.43%
1.78M
48.03%
1.47M
17.84%
1.61M
10.17%
2.15M
33.46%
2.60M
20.71%
change in working capital
1.85M
-
-1.25M
167.60%
3.28M
362.24%
-1.35M
141.28%
-1.73M
27.86%
-1.45M
16.30%
206K
114.23%
-2.26M
1,197.57%
-2.59M
14.46%
-833K
67.81%
15.01M
1,902.16%
accounts receivables
58K
-
-1.94M
3,443.10%
1.60M
182.72%
-11.92M
843.33%
9.05M
175.94%
inventory
-58K
-
1.94M
3,443.10%
11.92M
-
accounts payables
3.94M
-
-932K
123.63%
-2.49M
167.27%
-2.06M
17.38%
162K
107.87%
1.76M
988.27%
47K
97.33%
6.74M
14,242.55%
3.26M
51.61%
other working capital
-666K
-
-421K
36.79%
761K
280.76%
610K
19.84%
44K
92.79%
-4.02M
9,245.45%
-4.24M
5.34%
-7.57M
78.67%
2.70M
135.60%
other non cash items
-226K
-
-313K
38.50%
1.09M
447.28%
-315K
128.98%
62K
119.68%
966K
1,458.06%
707K
26.81%
346K
51.06%
366K
5.78%
441K
20.49%
77.00K
82.54%
net cash provided by operating activities
-17.31M
-
-22.82M
31.85%
-36.80M
61.22%
-52.86M
43.66%
-42.36M
19.86%
-31.06M
26.68%
-20.01M
35.57%
-15.30M
23.54%
-33.08M
116.16%
-41.89M
26.64%
-33.22M
20.69%
investments in property plant and equipment
-644K
-
-249K
61.34%
-664K
166.67%
-600K
9.64%
-1.31M
118.67%
-594K
54.73%
-79K
86.70%
-202K
155.70%
-192K
4.95%
-1.64M
754.69%
-4.21M
156.86%
acquisitions net
531K
-
14K
97.36%
-261K
1,964.29%
51K
119.54%
18K
64.71%
50K
177.78%
179K
258%
15K
91.62%
purchases of investments
-5.40M
-
-109.44M
1,927.89%
-28.09M
74.34%
-77.67M
176.52%
-40.30M
48.12%
-40.65M
0.86%
-21.07M
48.17%
-126.51M
500.52%
-42.12M
66.71%
-106.98M
153.99%
sales maturities of investments
3.40M
-
38.12M
1,021.03%
62.22M
63.23%
51.35M
17.47%
78.06M
52.03%
45.60M
41.59%
28.15M
38.27%
35.08M
24.63%
90.83M
158.89%
91.05M
0.25%
other investing activites
-531K
-
-14K
97.36%
261K
1,964.29%
net cash used for investing activites
-644K
-
-2.25M
248.76%
-71.99M
3,105.43%
33.53M
146.57%
-27.64M
182.43%
37.17M
234.50%
4.92M
86.75%
6.90M
40.10%
-91.57M
1,427.04%
47.24M
151.60%
-20.13M
142.60%
debt repayment
-3M
-
-1.56M
47.97%
-5.24M
235.49%
-5.20M
0.67%
-4.67M
-
-8M
71.42%
-9.08M
13.54%
-66K
-
-394K
496.97%
common stock issued
76.90M
-
143K
99.81%
42.48M
29,604.20%
379K
99.11%
9.32M
2,359.89%
25.22M
170.47%
109.95M
336.04%
5.47M
95.02%
66.62M
1,117.54%
common stock repurchased
36K
-
13K
63.89%
10K
23.08%
44K
-
105K
138.64%
dividends paid
-36K
-
-13K
63.89%
-10K
23.08%
-47.78M
-
other financing activites
53.74M
-
4.07M
92.42%
76.25M
1,772.13%
9.76M
87.21%
10.23M
4.83%
50K
99.51%
13K
74%
10K
23.08%
73K
630%
1K
98.63%
47.68M
4,767,800%
net cash used provided by financing activities
50.74M
-
2.51M
95.05%
147.92M
5,788.42%
4.70M
96.82%
52.70M
1,022.08%
-4.24M
108.04%
1.34M
131.52%
16.14M
1,108.31%
110.03M
581.56%
5.45M
95.05%
66.23M
1,115.01%
effect of forex changes on cash
-1
-
net change in cash
32.78M
-
-22.56M
168.81%
39.13M
273.45%
-14.64M
137.41%
-17.30M
18.17%
1.87M
110.82%
-13.75M
835.01%
7.74M
156.30%
-14.62M
288.79%
10.81M
173.96%
12.56M
16.22%
cash at beginning of period
3.67M
-
36.46M
892.03%
13.90M
61.88%
53.02M
281.50%
38.39M
27.60%
21.09M
45.06%
22.96M
8.87%
9.21M
59.89%
16.95M
84.06%
2.34M
86.22%
9.98M
327.27%
cash at end of period
36.46M
-
13.90M
61.88%
53.02M
281.50%
38.39M
27.60%
21.09M
45.06%
22.96M
8.87%
9.21M
59.89%
16.95M
84.06%
2.34M
86.22%
13.15M
462.76%
22.54M
71.49%
operating cash flow
-17.31M
-
-22.82M
31.85%
-36.80M
61.22%
-52.86M
43.66%
-42.36M
19.86%
-31.06M
26.68%
-20.01M
35.57%
-15.30M
23.54%
-33.08M
116.16%
-41.89M
26.64%
-33.22M
20.69%
capital expenditure
-644K
-
-249K
61.34%
-664K
166.67%
-600K
9.64%
-1.31M
118.67%
-594K
54.73%
-79K
86.70%
-202K
155.70%
-192K
4.95%
-1.64M
754.69%
-4.21M
156.86%
free cash flow
-17.95M
-
-23.07M
28.50%
-37.46M
62.36%
-53.46M
42.71%
-43.68M
18.30%
-31.66M
27.52%
-20.09M
36.53%
-15.50M
22.84%
-33.27M
114.58%
-43.53M
30.84%
-37.44M
13.99%

All numbers in USD (except ratios and percentages)